Misfolded insulin may be quietly driving diabetes
Researchers have identified that the misfolding of proinsulin proteins contributes to the stress and eventual failure of pancreatic beta cells in diabetes patients. The study suggests that enhancing the cellular machinery responsible for protein folding could offer a new therapeutic approach to protecting these cells.
Why it matters
This discovery provides a potential target for new diabetes treatments by addressing the underlying cellular mechanisms of the disease.
Much like paper must be folded into the correct shape to create an origami sculpture, proteins inside cells must form precise three-dimensional structures before they can function properly.
As prediabetes advances toward diabetes, this delicate process can begin to break down. Misfolded and defective proteins accumulate inside cells, creating stress that can damage the pancreatic cells responsible for producing insulin.
Researchers from Sanford Burnham Prebys Medical Discovery Institute and the University of Michigan reported new details about this process on June 1, 2026, in the Proceedings of the National Academy of Sciences . Their findings reveal how insulin-producing cells coordinate protein folding and what happens when that system falls out of balance. The work suggests that strengthening the cellular machinery responsible for folding proteins could help protect these cells from damage.
Why Insulin-Producing Beta Cells Become Overwhelmed
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in